National Peroxide Limited has deferred its previously scheduled board meeting. The meeting was originally scheduled for Monday, August 03, 2026, as intimated to the exchange on July 29, 2026 under Regulation 29 of the SEBI Listing Regulations.
The primary purpose of the board meeting was to consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2026 (Q1 FY27).
The deferment is attributed to "unavoidable circumstances." The company has committed to intimating the revised date of the board meeting to the stock exchange in due course, in compliance with the Listing Regulations.
Consequent to this deferment, the trading window in respect of the Company's securities will remain closed for all Designated persons and their immediate relatives. The closure period began on July 01, 2026 and will continue until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.
The disclosure is signed by Akshay Satasiya, Company Secretary and Compliance Officer, and is made with reference to the company's earlier intimation under Regulation 29.